Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Cash from Operations (2016 - 2025)

Aethlon Medical filings provide 15 years of Cash from Operations readings, the most recent being 1672649.0 for Q1 2025.

  • On a quarterly basis, Cash from Operations rose 34.8% to 1672649.0 in Q1 2025 year-over-year; TTM through Mar 2025 was 804814.0, a 107.95% increase, with the full-year FY2025 number at 7645532.0, up 24.52% from a year prior.
  • Cash from Operations hit 1672649.0 in Q1 2025 for Aethlon Medical, down from 2011000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 2214000.0 in Q3 2024 to a low of 3099078.0 in Q1 2022.
  • Median Cash from Operations over the past 5 years was 2377835.0 (2023), compared with a mean of 1872700.71.
  • Biggest five-year swings in Cash from Operations: crashed 88.01% in 2021 and later skyrocketed 184.57% in 2024.
  • Aethlon Medical's Cash from Operations stood at 2718118.0 in 2021, then rose by 28.22% to 1951114.0 in 2022, then decreased by 21.87% to 2377835.0 in 2023, then skyrocketed by 184.57% to 2011000.0 in 2024, then crashed by 183.17% to 1672649.0 in 2025.
  • The last three reported values for Cash from Operations were 1672649.0 (Q1 2025), 2011000.0 (Q4 2024), and 2214000.0 (Q3 2024) per Business Quant data.